Aurelio B Castrellon, MD

Aurelio Castrellon
Breast Medical Oncology

Primary Office
603 N Flamingo Road
Ste 157
Pembroke Pines, FL 33028
Alternate Location
1150 N 35th Avenue
Suite 170
Hollywood, FL 33021

Meet the Physician

Dr. Aurelio Castrellon is a medical oncologist with board certifications in medical oncology, hematology and internal medicine. He earned his medical degree from the Universidad de Panama School of Medicine in 2000, and completed his internship and residency in internal medicine at Jackson Memorial Hospital in association with the University of Miami/Miller School of Medicine in 2006. He completed his fellowship in hematology and medical oncology at Jackson Memorial Hospital and the University of Miami Sylvester Comprehensive Cancer Center in 2009. There, he spent most of his training working with world-renowned authorities in the treatment of breast cancer.

Dr. Castrellon then moved to New Mexico, where he practiced medical oncology for five years, with a particular interest in breast cancer. He focused on early detection and multidisciplinary treatments as the most effective methods to help improve breast cancer outcomes.

At Memorial, Dr. Castrellon is dedicated to breast health and to fostering an environment of early screening, detection and leading-edge care.

  • Portuguese


Awards and honors

  • Eric Reiss Award for Excellent Teaching Resident, Jackson Memorial Hospital, 2005

Professional organizations

  • American Society of Clinical Oncology
  • American Society of Hematology
  • American College of Physicians

Recent publications

  • “Study of Nabpaclitaxel, Bevacizumag and Gemcitabine as First-line Therapy for Patients with HER2-negative MBC,” Breast Cancer Research and Treatment, 2010
  • “Nasopharyngeal Carcinoma: Alternative Treatment Options After Disease Progression,” Expert Review of Anticancer Therapy, 2010
  • “Crohn’s Disease Complicated by Primary Gastrointestinal Hodgkin’s Lymphoma Presenting with Small Bowel Perforation,” Journal of Gastrointestinal and Liver Diseases, 2009
  • “How Important is Histology in Treatment Selection for Non-Small-Cell Lung Cancer Patients?” Cancer Therapy, 2009
  • “Lapatinib Plus Capecitabine Resolved Human Epidermal Growth Factor Receptor 2-Positive Brain Metastases,” American Journal of Therapeutics, 2009
  • “Second Line Chemotherapy for Non-Small-Cell Lung Cancer,” Clinical Lung Cancer, 2009


  • Universidad De Panama, 2000
  • Jackson Memorial Hospital, 2006, Internal Medicine
  • Jackson Memorial Hospital, 2009, Oncology
  • American Board of Internal Medicine-Hematology
  • American Board of Internal Medicine-Internal Medicine
  • American Board of Internal Medicine-Oncology

Related Physicians